News | Artificial Intelligence | April 02, 2019

Lunit Showcases AI Solution for Breast Cancer at SBI 2019

Lunit Insight for Mammography expected to get regulatory approvals beginning in July

Lunit Showcases AI Solution for Breast Cancer at SBI 2019

April 2, 2019 — Medical artificial intelligence (AI) startup Lunit announced its attendance at the Society of Breast Imaging (SBI) 2019 symposium, April 4-7 in Hollywood, Fla., where it will showcase its latest product for breast cancer detection, Lunit Insight for Mammography.

According to Lunit, the product is soon to be available for commercial sales, as the company is expecting to gain regulatory approvals in different regions. Lunit CEO Brandon Suh said Korea Ministry of Food and Drug Safety (MDFS) approval is expected as early as July 2019, followed by European CE approval by September 2019 and U.S. Food and Drug Administration (FDA) approval by early 2020.

Lunit Insight for Mammography was first revealed during the 2018 Radiological Society of North America annual meeting (RSNA 2018), presenting a 97 percent level of accuracy in the detection of breast cancer. Suh noted that false negative rates for mammography range from 10-30 percent, with false positive rates at around 95 percent. According to Suh, this costs more than $4 billion dollars for unnecessary recalls in the U.S. alone. He said that Lunit aims to reduce these costs by pulling more accurate information from accessible basic tests like mammography and use this clinically accurate information to increase efficiency in diagnostics.

Lunit is also developing what it calls a more sophisticated AI solution for digital breast tomosynthesis (DBT). DBT has been demonstrated by various large-scale studies to be superior to mammography in terms of breast cancer screening performance.

For more information: www.lunit.io

Related Content

The impact of deploying artificial intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients.

Getty Images

News | Artificial Intelligence | June 15, 2021
June 15, 2021 — The impact of deploying ...
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.

Getty Images

News | Women's Health | June 15, 2021
June 15, 2021 — The prevalence of genetic mutations associated with breast cancer in Black and white women is the sam
Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

News | SPECT Imaging | June 14, 2021
June 14, 2021 — An advanced artificial i...
The new X-ray scanner can provide detailed information about the internal makeup of rocks, which could be useful for archaeologists studying fossils or miners making decisions about which ore to use in their extraction facilities. Image courtesy of Joel Greenberg, Duke University

The new X-ray scanner can provide detailed information about the internal makeup of rocks, which could be useful for archaeologists studying fossils or miners making decisions about which ore to use in their extraction facilities. Image courtesy of Joel Greenberg, Duke University

News | X-Ray | June 10, 2021
June 10, 2021 — Engineers at Duke University have demonstrated a prot
Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

News | Breast Imaging | June 08, 2021
June 8, 2021 — Reporting at the 2021 annual meeting of the American S...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
Chest X-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients. Image courtesy of University of Waterloo

Chest X-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients. Image courtesy of University of Waterloo

News | Coronavirus (COVID-19) | June 03, 2021
June 3, 2021 — Artificial intelligence
Prof. Jayant Vaidya, lead author of the study, University College London surgery and interventional science, performs a TARGI-IORT procedure. A small ball-shaped device placed inside the breast, directly where the cancer had been. The single-dose treatment lasts for around 20-30 minutes and replaces the need for extra hospital visits in eight out of ten cases.

Prof. Jayant Vaidya, lead author of the study, University College London surgery and interventional science, performs a TARGI-IORT procedure. A small ball-shaped device placed inside the breast, directly where the cancer had been. The single-dose treatment lasts for around 20-30 minutes and replaces the need for extra hospital visits in eight out of ten cases.

News | Radiation Oncology | June 02, 2021
June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional rad
A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Ultrasound Imaging | June 01, 2021
June 1, 2021 — According to an open-access Editor's Choice article in ARRS' ...